CEFAZOLIN SODIUM
Total Payments
$503,733
Transactions
37
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $55,940 | 9 | 0 |
| 2020 | $21,035 | 4 | 0 |
| 2019 | $426,757 | 24 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $503,733 | 37 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| SAFETY OF 1 G AND 2 G OF CEFAZOLIN IN PEDIATRIC SUBJECTS | B. Braun Medical Inc. | $447,793 | 0 |
| PHARMACOKINETICS AND SAFETY OF CEFAZOLIN 3GM DUPLEX IN ADULTS | B. Braun Medical Inc. | $55,940 | 0 |
Top Doctors Receiving Payments for CEFAZOLIN SODIUM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Little Rock, AR | $503,733 | 37 |
Ad
Manufacturing Companies
- B. Braun Medical Inc. $503,733
Product Information
- Type Drug
- Total Payments $503,733
- Total Doctors 0
- Transactions 37
About CEFAZOLIN SODIUM
CEFAZOLIN SODIUM is a drug associated with $503,733 in payments to 0 healthcare providers, recorded across 37 transactions in the CMS Open Payments database. The primary manufacturer is B. Braun Medical Inc..
Payment data is available from 2019 to 2023. In 2023, $55,940 was paid across 9 transactions to 0 doctors.
The most common payment nature for CEFAZOLIN SODIUM is "Unspecified" ($503,733, 100.0% of total).
CEFAZOLIN SODIUM is associated with 2 research studies, including "SAFETY OF 1 G AND 2 G OF CEFAZOLIN IN PEDIATRIC SUBJECTS" ($447,793).